5th European Congress of Medical Physics

Do protons offer dosimetric advantage over intensity modulated photons in head and neck cancer reirradiation?

Clinical radiotherapy

Clinical radiotherapy (self-study)

Eposter self-study

A dosimetric and toxicity analysis of cardiac substructures in left-sided breast cancer radiotherapy

more information:<br><br><a href="https://ecmp2024.org/fileadmin/media/ecmp/2024/docs/PDF/ECPMP2024_ESMPEClinicalTrials.pdf" class="extern" target="_blank">programme overview (pdf)</a>

Saturn

The role of medical physicists in clinical trials (III)

Special session

The role of medical physicists in clinical trials (IV)

Audimax

Keynote: Automated treatment planning – Where will/should it go? by Professor Ben Heijmen

Clinical radiotherapy: Dose calculations

Clinical RT

The talk will present the results of an EFOMP-driven survey regarding the actual status of the role of the medical physicist in clinical trials across Europe, also justifying the creation of the working group. A summary of the guidelines prepared by the working group will be presented.

The wide role of medical physicists in clinical trials: Summary of EFOMP work group

Prof. Dr. Loredana G. Marcu

Chair

Speaker

Further involvements